Document and Entity Information [Abstract] Document Type Document Quarterly Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address State Or Province Entity Address, Address Line One Entity Address, City or Town Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Entity Ex Transition Period Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Bristol-Myers Squibb Collaboration Assets [Abstract] Assets Assets, Current [Abstract] Current assets Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Short-term Investments Short-term investments Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current Total current assets Property, Plant and Equipment, Net Property and equipment, net Property and equipment, net Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Operating lease right-of-use asset, net Restricted Cash, Noncurrent Restricted cash Cash on deposit Long-term Investments Long-term investments Deposits Assets, Noncurrent Security deposits and non-current assets Assets Total assets Liabilities and Equity [Abstract] Liabilities and stockholders' equity Liabilities, Current [Abstract] Current liabilities Accounts Payable, Current Accounts payable Accounts payable Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer) Accrued Expenses And Other Liabilities, Current Accrued expenses and other liabilities Total accrued expenses and other liabilities Deposit Liability, Current Deposit liability Deferred Revenue, Current Less current portion of deferred revenue Deferred revenue, current Liabilities, Current Total current liabilities Operating Lease, Liability, Noncurrent Operating lease liability, long term Security Deposit Liability Security deposit, non-current The non-current portion, due after one year or beyond the normal operating cycle, if longer, of deposits held other than customer deposits. Deposit Liability, Noncurrent Deposit liability, non-current Deferred Revenue, Noncurrent Deferred revenue, non-current Total long-term deferred revenue Liabilities Total liabilities Commitments and Contingencies Commitments and contingencies (Note 10) Members' equity: Stockholders' equity: Preferred Stock, Value, Issued Preferred stock, $ 0.0001 par value, 10,000,000 shares authorized and 0 shares issued and outstanding at December 31, 2023 and December 31, 2022 Common Unit, Issuance Value Common stock, $0.0001 par value, 125,236,190 shares authorized; 60,335,701 and 58,473,660 shares issued and outstanding at December 31, 2023 and December 31, 2022, respectively Members' Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive loss Stockholders' Equity Attributable to Parent Ending balance Beginning balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred Stock, Shares Authorized Preferred Stock, Shares Issued Preferred Stock, Shares Outstanding Common Stock, Par or Stated Value Per Share Common stock, par value Common Stock, Shares Authorized Common Stock, Shares, Issued Common stock issued and sold Common Stock, Shares, Outstanding CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS Revenue from Contract with Customer, Excluding Assessed Tax Collaboration revenue Operating expenses Research and Development Expense (Excluding Acquired in Process Cost) Research and development General and Administrative Expense. General and administrative Operating Expenses. Total operating expenses Operating Income (Loss) Loss from operations Interest Expense Interest expense Interest expense Interest Income, Other Interest income Other Nonoperating Income (Expense) Other income (expense) Nonoperating Income (Expense) Total other income (expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Loss before provision for income taxes Income Tax Expense (Benefit) Provision for income taxes Income tax expense (benefit) Earnings Per Share, Basic Net loss per common share Basic (in dollars per share) Basic net loss per common share Weighted Average Number of Shares Outstanding, Basic Weighted average common shares outstanding Basic (in shares) Weighted-average common shares for basic net loss per share Comprehensive Income (Loss), Net of Tax, Attributable to Parent [Abstract] Other comprehensive loss OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment, before Tax Unrealized (loss) gain on investments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation gain (loss) Foreign currency translation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock Additional Paid-in Capital Accumulated Deficit Accumulated Other Comprehensive Loss Increase (Decrease) in Stockholders' Equity [Roll Forward] Shares, Outstanding Ending Balance (in shares) Beginning Balance (in shares) Stock Issued During Period, Value, New Issues Aggregate purchase price excluding premium Issuance of sommon stock upon the exercise of ATM, net of underwriting discounts and commissions and other issuance costs Stock Issued During Period, Shares, New Issues Issuance of sommon stock upon the exercise of ATM, net of underwriting discounts and commissions and other issuance costs (in shares) Common stock issued Equity impact of the value of new stock issued during the period. Includes shares issued to collaboration partner. Stock Issued During Period to Collaboration Partner Issuance of stock to collaboration partner Equity impact of the value of new stock issued during the period. Includes shares issued to collaboration partner. Stock Issued During Period to Collaboration Partner, Shares Issuance of stock to collaboration partner (in shares) Stock Issued During Period, Value, Stock Options Exercised Issuance of common stock upon the exercise of stock options Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Exercised Issuance of common stock upon the exercise of stock options (in shares) Stock Issued During Period, Value, Restricted Stock Award, Gross Vesting of restricted stock Stock Issued During Period, Shares, Restricted Stock Award, Gross Vesting of restricted stock (in shares) Value of stock issued as a result of the vesting of early exercise of stock options Stock Issued During Period, Value, Vesting of Early Exercise Stock Options Vesting of early exercise stock options Number of stock issued as a result of the vesting of early exercise of stock options. Stock Issued During Period, Shares, Vesting of Early Exercise Stock Options Vesting of early exercise stock options (in shares) Value of stock issued as a result of the vesting of Restricted Stock Units Stock Issued During Period, Value, Restricted Stock Units Vesting of restricted stock units Shares of stock issued as a result of the vesting of Restricted Stock Units Stock Issued During Period, Shares, Restricted Stock Units Vesting of restricted stock units (in shares) OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax Unrealized loss on investments APIC, Share-based Payment Arrangement, Increase for Cost Recognition Stock based compensation CONSOLIDATED STATEMENTS OF CASH FLOWS Cash flows from operating activities Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Adjustments to reconcile net loss to net cash used in operating activities: Depreciation Depreciation Amortization of deferred financing cost Amortization of debt issuance costs, including end of term fee accretion Represents amount of non-cash operating lease expense. Non Cash Operating Lease Expense Non-cash operating lease expense (benefit) Share-based Payment Arrangement, Noncash Expense Stock based compensation Accretion (Amortization) of Discounts and Premiums, Investments Amortization/accretion of investments Change in operating assets and liabilities: Amount of increase (decrease) in escrow deposits. Increase (Decrease) in Escrow Deposit Escrow deposit Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other assets Increase (Decrease) in Operating Lease Liability Operating lease liability Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities Increase (Decrease) in Security Deposits Non-current security deposit Net Cash Provided by (Used in) Operating Activities Cash used in operations Net cash used in operating activities Cash flows from investing activities Payments to Acquire Property, Plant, and Equipment Acquisition of property and equipment Payments to Acquire Debt Securities, Available-for-sale Acquisition of fixed maturity securities, available for sale Proceeds from Sale of Debt Securities, Available-for-sale Sale of fixed maturity securities, available for sale Net Cash Provided by (Used in) Investing Activities Net cash provided by (used in) investing activities Cash flows from financing activities The cash inflow from At the Market, net of proceeds. Proceeds from At the Market, Net of Issuance Costs Proceeds from ATM, net of issuance costs Proceeds from Issuance of Common Stock Proceeds from issuance of common stock and ESPP Gross proceeds Net Cash Provided by (Used in) Financing Activities Net cash (used in) provided by financing activities Cash and Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net (decrease) increase in cash, cash equivalents, and restricted cash Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Cash, cash equivalents and restricted cash, end of period Cash, cash equivalents and restricted cash, beginning of period Cash, cash equivalents, and restricted cash Supplemental disclosure of cash and non-cash operating activities: Interest Paid, Excluding Capitalized Interest, Operating Activities Cash paid for interest Supplemental disclosure of non-cash investing and financing activities: Capital Expenditures Incurred but Not yet Paid Purchase of property and equipment, accrued and unpaid Organization and description of the business Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Organization and description of the business Summary of significant accounting policies and basis of presentation Basis of Presentation and Significant Accounting Policies [Text Block] Summary of significant accounting policies and basis of presentation Reduction in force Restructuring and Related Activities Disclosure [Text Block] Reduction in force Financial instruments and fair value measurements Fair Value Disclosures [Text Block] Financial instruments and fair value measurements Property and equipment, net Property, Plant and Equipment Disclosure [Text Block] Property and equipment, net Accrued expenses and other liabilities. Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block] Accrued expenses and other liabilities Long-term debt Debt Disclosure [Text Block] Long-term debt Bristol-Myers Squibb Collaboration Revenue from Contract with Customer [Text Block] Bristol-Myers Squibb Collaboration Commitments and Contingencies. Commitments and Contingencies Disclosure [Text Block] Commitments and Contingencies Leases Leases of Lessee Disclosure [Text Block] Leases Income taxes Income Tax Disclosure [Text Block] Income taxes Basic and diluted net loss per common share Earnings Per Share [Text Block] Basic and diluted net loss per common share Stock-based compensation Share-based Payment Arrangement [Text Block] Stock-based compensation Related party transactions Related Party Transactions Disclosure [Text Block] Related party transactions Equity [Abstract] Equity [Text Block] Common Stock Subsequent Events Subsequent Events [Text Block] Subsequent Events Basis of Accounting, Policy [Policy Text Block] Basis of presentation Segment Reporting, Policy [Policy Text Block] Segment information Use of Estimates, Policy [Policy Text Block] Use of estimates Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of credit risk and other risks and uncertainties Fair Value Measurement, Policy [Policy Text Block] Fair value of financial instruments Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block] Restricted cash Disclosure of accounting policy for fixed maturity securities. Fixed Maturity Securities Policy [Policy Text Block] Investments Property, Plant and Equipment, Policy [Policy Text Block] Property and equipment, net Research and Development Expense, Policy [Policy Text Block] Research and development expenses Share-based Payment Arrangement [Policy Text Block] Stock-based compensation Disclosure of accounting policy for warrants. Warrants Policy [Policy Text block] Warrants Foreign Currency Transactions and Translations Policy [Policy Text Block] Foreign currency translation Earnings Per Share, Policy [Policy Text Block] Basic and diluted net loss per common shares Revenue [Policy Text Block] Collaboration revenue New Accounting Pronouncements, Policy [Policy Text Block] Recent accounting pronouncements Schedule of Cash and Cash Equivalents [Table Text Block] Schedule of reconciliation of the Company's cash, cash equivalents, and restricted cash Share-based Payment Arrangement, Activity [Table Text Block] Reconciliation of shares issued and outstanding Fair Value Measurements, Recurring and Nonrecurring [Table Text Block] Schedule of assets measured at fair value by level within the fair value hierarchy Schedule of Available-for-sale Securities Reconciliation [Table Text Block] Schedule of investments in fixed maturity securities Investments Classified by Contractual Maturity Date [Table Text Block] Schedule of maturities of fixed maturity available-for-sale securities Property, Plant and Equipment [Table Text Block] Schedule of summary of property and equipment, net Schedule of Accrued Liabilities [Table Text Block] Schedule of summary of accrued expenses Tabular disclosure of debt interest expenses. Schedule of Interest Expenses Of Debt [Table Text Block] Schedule of interest expense attributable to the loan agreement The Entire disclosure of total transaction price to the identified performance obligations Total Transaction Price to The Identified Performance Obligations [Table text block] Schedule of transaction price unsatisfied Lease, Cost [Table Text Block] Schedule of components of lease expenses Schedule of supplemental balance sheet information related to leases. Schedule of Supplemental Balance Sheet Information related to leases Tabular disclosure of supplemental information related to leases. Schedule of Supplemental Information Related to Leases [Table Text Block] Schedule of supplemental lease term and discount rate information related to leases Schedule of supplemental cash flow information related to leases. Schedule of Supplemental Cash Flow Information Related to Leases Schedule of supplemental cash flow information related to leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of Future minimum lease payments of operating leases Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Schedule of potential shares of common stock excluded Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Restricted stock units Restricted stock units Unvested restricted stock units Restricted stock Restricted stock award subject to future vesting Restricted stock awards Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Stock based compensation Tabular disclosure of shares reserved for issuance under share-based payment arrangement. Share-Based Payment Arrangement, Shares Reserved for Issuance [Table Text Block] Schedule of reserved shares of common stock Tabular disclosure of shares available for grant for award under share-based payment arrangement. Share-Based Payment Arrangement, Shares Available for Grant [Table Text Block] Schedule of common stock available under 2021 Incentive Plan Share-based Payment Arrangement, Option, Activity [Table Text Block] Schedule of stock option activity Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] Schedule of weighted-average assumptions Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block] Schedule of stock-based compensation expense and by award type Share-based Payment Arrangement, Restricted Stock Unit, Activity [Table Text Block] Schedule of restricted stock activity Schedule of Capitalization, Equity [Table] Schedule of Capitalization, Equity [Line Items] Organization and description of the business Sale of Stock, Consideration Received on Transaction Proceeds from ATM, net of issuance costs Refers to the amount of underwriting discounts and commissions related to sale of stock. Sale Of Stock Underwriting Discounts And Commissions Amount of commissions Amount of cash and cash equivalents on short and long term investments. Cash And Cash Equivalents Short And Long Term Investments Amount of cash and cash equivalents on short and long term investments The rate of restructuring plan resulted in a reduction in the Company's workforce. Workplace Reduction Restructuring Percentage Reduction percentage Number of Operating Segments Number of operating segment Restricted Cash and Cash Equivalents Restricted cash Property, Plant and Equipment, Useful Life Estimated useful lives of the assets Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend rate Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number Less: unvested restricted stock awards (Note 16) Total Unvested Total Unvested Schedule of Restructuring and Related Costs [Table] Restructuring Type [Axis] Type of Restructuring [Domain] Employee Severance [Member] Income Statement Location [Axis] Income Statement Location [Domain] General and administrative Research and development Restructuring Cost and Reserve [Line Items] Reduction in force Payments for Restructuring Amount of cash-based expenses Restructuring Reserve, Current Amount of non-cash stock-based compensation charge Restructuring and Related Cost, Expected Cost Amount of remaining outstanding liabilities related to the reduction Fair Value, Recurring and Nonrecurring [Table] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Domain] Level 1 Level 2 Financial Instrument [Axis] Financial Instruments [Domain] U.S. Treasury Corporate bonds Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Financial instruments and fair value measurements Cash and Cash Equivalents, Fair Value Disclosure Cash equivalents Debt Securities, Available-for-Sale, Excluding Accrued Interest, Noncurrent Debt securities Assets, Fair Value Disclosure Total assets Amount of transfers of assets measured on a recurring basis out of Level 1 of the fair value hierarchy into Level 2. Fair Value, Assets, Level 1 to Level 2 Transfers, Amount One Transfer of assets from level 1 to level 2 Amount of transfers of assets measured on a recurring basis out of Level 2 of the fair value hierarchy into Level 1. Fair Value, Assets, Level 2 to Level 1 Transfers, Amount One Transfer of assets from level 2 to level 1 Debt Securities, Available-for-sale [Table] Debt Securities, Available-for-sale [Line Items] Financial instruments and fair value measurements Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, before Allowance for Credit Loss, Current Amortized Cost Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax Gross Unrealized Gains Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax Gross Unrealized Losses Debt Securities, Available-for-Sale, Excluding Accrued Interest Fair Value Debt securities Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Less than one year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five One to five years Debt Securities, Available-for-Sale, Unrealized Loss Position, Number of Positions Number of available-for-sale investment debt securities Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss Amount of accrued interest receivable on available-for-sale investment debt securities Debt Securities, Available-for-Sale, Accrued Interest, after Allowance for Credit Loss, Statement of Financial Position [Extensible Enumeration] Property, Plant and Equipment [Table] Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Domain] Represents information pertaining to lab equipment. Lab equipment Leasehold improvements Construction in progress Computer software and equipment Furniture and fixtures Property, Plant and Equipment [Line Items] Property and equipment, net Property, Plant and Equipment, Gross Gross total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: Accumulated depreciation Employee-related Liabilities, Current Payroll and bonuses Carrying value as of the balance sheet date of obligations incurred through that date for A\accrued clinical trial related costs. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued clinical trial related costs Accrued clinical trial related costs Accrued Professional Fees, Current Professional and legal fees Operating Lease, Liability, Current Operating lease liability, current Operating lease liability, current Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Due to Related Parties, Current Other Accrued expenses Schedule of Long-term Debt Instruments [Table] Debt Instrument [Line Items] Long-term debt The amount of end of term fee of debt. Debt Instrument, End of Term Fee Plus: End of term fee Debt instrument end of term fee Debt and Lease Obligation Long-term debt, net Debt Instrument [Axis] Debt Instrument, Name [Domain] Represents information relating to Term Loan Agreement with Hercules Capital, Inc. Loan Agreement Represents information relating to Term Loan Agreement tranche 1 Tranche 1 Debt Instrument, Face Amount Loan amount Payment for Debt Extinguishment or Debt Prepayment Cost Debt prepayment charges The amount of prepayment charge on debt instrument. Debt Instrument Prepayment Charge Debt instrument prepayment charge Percentage of prepayment charge on original principal amount of debt. Percentage of Prepayment Charge on Original Principal Amount of Debt Percentage of prepayment charge on original principal amount of debt Class of Warrant or Right, Number of Securities Called by Warrants or Rights Warrants to purchase units Warrants and Rights Outstanding, Term Warrants term Class of Warrant or Right, Exercise Price of Warrants or Rights Warrants exercise price Fair value of warrants or rights at the issuance. Class of Warrant or Right, Fair Value Fair value of the warrants at issuance Interest Expense, Debt Interest expense Related Party Transaction [Axis] Related Party Transaction [Domain] Represents the information pertaining to FCDI Collaboration Agreement. FCDI Collaboration Agreement Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Represents the information pertaining to Bristol Myers Squibb Company Collaboration Agreement. Collaboration Agreement Number of collaboration programs under the collaboration agreement. Collaboration Agreement, Number of Collaboration Programs Number of collaboration programs Number of additional collaboration programs under the collaboration agreement. Collaboration Agreement, Additional Number of Collaboration Programs Additional number of collaboration programs The amount of upfront cash payment receivable under the collaboration agreement. Collaboration Agreement, Upfront Cash Payment, Receivable Upfront cash payment receivable The amount of milestone payments receivable upon achievement of certain development and regulatory milestones. Collaboration Agreement, Milestone Payments Receivable upon Achievement of Certain Development and Regulatory Milestones Milestone payments receivable upon achievement of certain development and regulatory milestones The amount of sales-based milestone payments receivable under the collaboration agreement. Collaboration Agreement, Sales Based Milestone Payments Receivable Sales-based milestone payments Premium value per share of common stock. Common Stock, Premium Value Per Share Common stock, premium per share Amount of common stock premium. Common Stock, Value, Premium Premium amount of common stock The number of commitments represent distinct performance . Number of Commitments Number of Commitments Total transaction price Total transaction price Disaggregation of Revenue [Table] Product and Service [Axis] Product and Service [Domain] This member standards for option rights Option rights This member stands for research and development services Research and development services Contract with Customer, Basis of Pricing [Axis] Contract with Customer, Basis of Pricing [Domain] This member stands for transaction price Transaction price This member stands for Cumulative collaboration revenue recognized Cumulative collaboration revenue recognized Disaggregation of Revenue [Line Items] Bristol-Myers Squibb Collaboration Contract with Customer, Liability, Revenue Recognized Cumulative collaboration revenue recognized Deferred Revenue Total Loss Contingencies [Table] Other Commitments [Axis] Other Commitments [Domain] Represents the information pertaining to Distributed bio master agreement. Distributed Bio Master Service Agreement Represents the information pertaining to iCELL Inc. Sublicense Agreement. iCELL Inc. Sublicense Agreement Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum Balance Sheet Location [Axis] Balance Sheet Location [Domain] Primary financial statement caption encompassing accrued and other liabilities. Accrued expenses and other liabilities Loss Contingencies [Line Items] Commitments and Contingencies Amount of milestone payment. Commitment, Milestone Payments Milestone payments The amount of milestone payments due in collaborative arrangement. Collaborative Arrangement, Milestone Payments, Payable Milestone payments due Other Commitment Accrued expenses Amount of development and regulatory approval milestone payments. Development And Regulatory Approval Milestone Payments Development and regulatory approval milestone payments Lessee, Lease, Description [Table] Minimum Lessee, Lease, Description [Line Items] Refers to security deposits on certain leases. Security Deposits on Leases Amount of security deposits on certain leases Lessor, Operating Lease, Term of Contract Initial lease terms Lease, Cost [Abstract] Operating lease expense: Operating Lease, Cost Fixed lease cost Variable Lease, Cost Variable lease cost Short-term Lease, Cost Short term lease expense Lease, Cost Total operating lease expense Operating Lease, Liability Total Total operating lease liability Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease terms (years) - operating leases Operating Lease, Weighted Average Discount Rate, Percent Weighted-average discount rate - operating leases Supplemental Cash Flow Information [Abstract] Supplemental cash flow information Proceeds from Lease Payment, Operating Activity Operating cash flows from operating leases Lessee, Operating Lease, Liability, Payment, Due [Abstract] Operating Leases Lessee, Operating Lease, Liability, to be Paid, Year One 2024 Lessee, Operating Lease, Liability, to be Paid, Year Two 2025 Lessee, Operating Lease, Liability, to be Paid, Year Three 2026 Lessee, Operating Lease, Liability, to be Paid, Year Four 2027 Lessee, Operating Lease, Liability, to be Paid, Year Five 2028 Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Lessee, Operating Lease, Liability, to be Paid Total lease payments Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less: imputed Interest Amount of lessee tenant incentive receivable. Lessee Tenant Incentive Receivable Less: Tenant incentive receivable Operating Loss Carryforwards [Table] Operating Loss Carryforwards [Line Items] Operating Loss Carryforwards Net operating loss carryforwards Net Income (Loss) Attributable to Parent [Abstract] Numerator Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Stock options to purchase common stock Represents information pertaining to early exercised stock options subject to future vesting. Early exercised stock options subject to future vesting Warrants Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Basic and diluted net loss per common share Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Securities excluded from the computation of diluted net loss per share Plan Name [Axis] Plan Name [Domain] Refers to the 2021 Incentive Plan 2021 Incentive Plan Represents the information pertaining to performance based RSU. Performance Based Restricted Stock Units [Member] Performance Based Restricted Stock Units Vesting [Axis] Vesting [Domain] Tranche 1. Tranche 1 Tranche2 Tranche 2 Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period Stock awards vesting period Restricted stock vesting period Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Shares authorized for issuance Additional shares authorized for issuance under share-based payment arrangement as percent of shares outstanding. Share-Based Compensation Arrangement by Share-Based Payment Award, Additional Shares Authorized as Percent of Outstanding Shares Percentage of common stock outstanding Increase in aggregate number of common shares reserved for issuance. Increase in Common Stock, Capital Shares Reserved for Future Issuance Increase in common stock reserved Shares reserved for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized Additional shares authorized for issuance Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant Ending balance Beginning balance Shares available for grant Share-based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable Stock reserved for issuance upon the exercise of previously granted stock options Conversion of Stock, Shares Issued Conversion of stock shares issued Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Vesting percentage Represents information pertaining to employee stock options and restricted stock units. Employee Stock Options and Restricted Stock Units [Member] Options and RSUs Employee stock purchase plan Employee stock purchase plan The number of shares under options and equity-based payment instruments other than stock options outstanding. Share-Based Compensation Arrangement by Share-Based Payment Award, Options and Equity Instruments Other than Options, Outstanding Options and RSUs issued and outstanding Common Stock, Capital Shares Reserved for Future Issuance Reserved shares of common stock for issuance Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross Options granted Granted Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period RSU's granted Granted The number of shares under options and equity-based payment instruments other than stock options, that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements. Share-Based Compensation Arrangement by Share-Based Payment Award, Options and Equity Instruments Other than Options, Forfeitures in Period Options and RSUs forfeited / cancelled Represents information pertaining to time based vesting. Time Based Vesting Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward] Shares Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Outstanding, ending (in shares) Outstanding, beginning (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Outstanding, ending Outstanding, beginning Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercised Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Forfeited Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price Cancelled Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract] Weighted Average Remaining Contractual Term (years) Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term Exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value Weighted average grant date fair value Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount Unrecognized compensation expense Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Unrecognized compensation expense expected to be recognized over a weighted average period Unrecognized compensation expense expected to be recognized over a weighted average period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest [Abstract] Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Outstanding, ending Outstanding, beginning Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value Exercisable weighted-average assumptions fair value of stock option granted Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected option term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table] Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] Stock-based compensation Share-based Payment Arrangement, Expense Total stock-based compensation Represents the information pertaining to unvested restricted stock with time based vesting. Unvested restricted stock with time-based vesting Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward] Shares Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeited in Period Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period Vested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract] Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Total Unvested Total Unvested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value Granted Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value Forfeited Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value Vested Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Unrecognized compensation expense Refers to the 2021 Employee Stock Purchase Plan Employee Stock Purchase Plan 2021 Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Related party transactions Related Party Transaction, Amounts of Transaction Payment to related party Research and Development Expense Research and development Legal Fees Legal fees Schedule of Stock by Class [Table] Refers to 2024 Sales Agreement Sales Agreement Class of Stock [Line Items] Common Stock Subsequent Event [Table] Refers to Securities Purchase Agreement Securities Purchase Agreement Class of Stock [Axis] Class of Stock [Domain] Represents information relating to Private Placement Shares. Private Placement Shares [Member] Asset Acquisition [Axis] Asset Acquisition [Domain] Asset acquisition. Clade Therapeutics, Inc Subsequent Event [Line Items] Subsequent Events Share Price Issuance price per share Carrying value of specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period classified as current. Offering Costs, current Agent fees and offering expenses Asset Acquisition, Consideration Transferred, Contingent Consideration Consideration, Cash Paid Asset Acquisition, Consideration Transferred, Equity Interest Issued and Issuable Consideration, shares